MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.